Diese Seite wurde automatisch übersetzt und die Genauigkeit der Übersetzung wird nicht garantiert. Bitte wende dich an die englische Version für einen Quelltext.

Single Limb Resistance Training in Patients With Chronic Obstructive Pulmonary Disease (COPD) (COPD)

19. Juni 2012 aktualisiert von: Dr. Karin Wadell, Umeå University

Effects of High-repetitive Single Limb Training on Exercise Capacity and Quality of Life in Patients With COPD Compared to a Control Group - A Prospective, Single Blind, Randomized Controlled Multicenter Trial

The chronic airflow limitation in chronic obstructive pulmonary disease (COPD) patients resulting in increased dyspnea during physical activity restricts many COPD patients ability to perform exercises in general and whole-body exercises in particular. Single limb training performed as one-legged cycling has been shown effective in patients with COPD. This exercise regime results in less stress on the ventilatory system as training is executed using a simultaneously smaller muscle mass. However, the positive physiological effects of exercise training only occur in the involved muscle(s). To be of benefit for patients daily life, all relevant muscles should be included in exercise training. The aim of the current randomized controlled multicenter trial (RCT) is to determine the effects of high-repetitive single limb exercises (HRSLE) in combination with COPD specific patient education, compared to the COPD specific patient education alone in patients with moderate to very severe (stage II-IV) COPD.

Studienübersicht

Detaillierte Beschreibung

Chronic obstructive pulmonary disease (COPD) is a major cause of chronic morbidity and mortality in the world. It is one of our most common chronic diseases and up to 700.000 people is estimated to suffer from COPD in Sweden. Exercise intolerance is the key disabling factor in COPD, with decreased exercise capacity, leg fatigue and dyspnea among the most frequently reported symptoms.

Different training modalities have been evaluated to uncover the most effective way of training patients with COPD. Traditionally research has used whole-body, or major muscle mass training regimes when investigating the effect of both endurance and resistance in COPD patients. However recent research have demonstrated positive effects using training regimes involving a simultaneous smaller muscle mass compared to traditional exercise. The concept of using this regime is to put less stress on the ventilator system when exercising to minimize the effect of the chronic airflow limitation and to enhance the ability to be able to exercise for this group of patients compared to traditional training using major muscle mass exercise regimes. Although recent research have shown positive effects of single limb training using one-legged cycling, one major limitation is that only a small amount of important muscles for COPD patients are incorporated. Therefore, the aim of this study is to: (i) examine the effect of a single limb exercise regime on local muscle endurance, maximal strength, quality of life, dyspnea, walking capacity, self-efficacy, anxiety and depression, (ii) to examine if the physiological effects differ between man and women and (iii) to investigate if this exercise regime is feasible and safe to use for patients with COPD.

Patients diagnosed with moderate to very severe COPD according to GOLD criteria will be randomly assigned to constitute either an exercise or control group The exercise group will participate in a high-repetitive single limb exercise regime, consisting of upper and lower limb exercises with elastic resistance, compromised of three sessions per week over a period of 8 weeks. The exercise regime will be performed in group at Umeå University Hospital of Northern Sweden, and at Huddinge University Hospital, Sweden supervised by experienced physiotherapists. Both the exercise and control group will receive four sessions of standardized patient education during the 8 week intervention period. After completion of the study, patients in the control group will be offered participation in the single limb exercise regime.

The most important upper and lower extremity muscles for COPD patients are identified and exercises are designed specific to each of these. The exercise regime consists of 8 exercises, 4 upper extremity and 4 lower extremity exercises. Starting position and performance of the exercises are standardized and the resistance individually adjusted and progressed according to rated dyspnea and muscle fatigue.

Before and after the 8 week intervention period the following information will be collected. Effects on maximal strength, muscular endurance, dyspnea, self-efficacy, anxiety and depression. The relationship between changes in health related variables and changes in exercise capacity, sex related differences in training effects, feasibility of the program, strategies to determine adequate starting resistance and provide accurate resistance for each involved movement and the relationship between muscle fatigue and dyspnea in the different exercise tests will also be analyzed.

Studientyp

Interventionell

Einschreibung (Tatsächlich)

44

Phase

  • Unzutreffend

Kontakte und Standorte

Dieser Abschnitt enthält die Kontaktdaten derjenigen, die die Studie durchführen, und Informationen darüber, wo diese Studie durchgeführt wird.

Studienorte

      • Huddinge, Schweden, 141 59
        • Huddinge University Hospital
      • Umeå, Schweden, 90187
        • Umeå University Hospital

Teilnahmekriterien

Forscher suchen nach Personen, die einer bestimmten Beschreibung entsprechen, die als Auswahlkriterien bezeichnet werden. Einige Beispiele für diese Kriterien sind der allgemeine Gesundheitszustand einer Person oder frühere Behandlungen.

Zulassungskriterien

Studienberechtigtes Alter

40 Jahre und älter (Erwachsene, Älterer Erwachsener)

Akzeptiert gesunde Freiwillige

Nein

Studienberechtigte Geschlechter

Alle

Beschreibung

Inclusion Criteria:

  1. Adults 40 years and above.
  2. Stable (no exacerbations within 4 weeks before start of baseline testing) moderate to very severe COPD, stage II-IV, according to GOLD criteria i.e. Forced expiratory volume in one second (FEV1)/ forced vital capacity (FVC) < 0.70, FEV1 < 80% predicted.
  3. Ex-smoker.
  4. Stable medical treatment (no changes < 4 weeks before start of baseline testing).
  5. Living less than 60 km from training facility.

Exclusion Criteria:

  1. Musculoskeletal, rheumatic, cardiac or neurological disorders that might affect the exercise performance in training and tests.
  2. Previous lung surgery.
  3. Acute exacerbations of COPD that require a change in pharmacological management within four weeks preceding the start of the intervention
  4. Long-term oxygen treatment.
  5. Participated in organized exercise training, > 2 times a week, within 6 months before start of intervention.
  6. Body mass index (BMI) < 18 kg/m2.

Studienplan

Dieser Abschnitt enthält Einzelheiten zum Studienplan, einschließlich des Studiendesigns und der Messung der Studieninhalte.

Wie ist die Studie aufgebaut?

Designdetails

  • Hauptzweck: Behandlung
  • Zuteilung: Zufällig
  • Interventionsmodell: Parallele Zuordnung
  • Maskierung: Single

Waffen und Interventionen

Teilnehmergruppe / Arm
Intervention / Behandlung
Aktiver Komparator: Control group
The control group will receive standardized patient education four times, once every two weeks, during the eight week intervention period.
The control group receives standardized patient education four times, once every two weeks, during the eight week intervention period. Each session will last 60 minutes, consisting of information regarding anatomy, physiology, causes and mechanisms of COPD, drugs, nutrition, aids and energy saving procedures. The information is the same as for the intervention group, given at separate occasions.
Experimental: High-repetitive single limb training
The experimental group will receive a high-repetitive single limb exercise regime, three times a week for two months. In addition, the exercise group will receive patient education at four occasions during the intervention period.
The high-repetitive single limb exercise regime consists of three sessions per week during eight weeks of exercise training, giving a total number of 24 sessions at each location (Umeå and Huddinge University hospitals). The exercise sessions are supervised and conducted by a physical therapist using a group format, six to eight participants in each group. Each session will span for 60 minutes, duration of the major components are: 10 min warm-up followed by 40 minutes of single limb training and 10min cool-down. In addition this experimental group also receives four sessions of patient education once every two week.

Was misst die Studie?

Primäre Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
Quality of life
Zeitfenster: Before single limb exercise regime and on completion (at 8 weeks)
The Swedish Self-Administered Standardized version of the Chronic Respiratory Disease Questionnaire (CRQ-SAS) will be used as primary outcome measure to asses quality of life
Before single limb exercise regime and on completion (at 8 weeks)
Functional lower extremity muscular endurance
Zeitfenster: Before single limb exercise regime and on completion (at 8 weeks)
To asses muscular endurance in the lower extremity the 6-minute walk test will be used as primary outcome measure.
Before single limb exercise regime and on completion (at 8 weeks)
Upper extremity muscular endurance
Zeitfenster: Before single limb exercise regime and on completion (at 8 weeks)
The 6-minute ring and pegboard test will be used as primary outcome measure for upper extremity muscular endurance
Before single limb exercise regime and on completion (at 8 weeks)

Sekundäre Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
Isokinetic maximal muscle strength
Zeitfenster: Before single limb exercise regime and on completion (at 8 weeks)
Maximal muscle strength in both upper and lower extremity will be evaluated with an isokinetic dynamometer
Before single limb exercise regime and on completion (at 8 weeks)
Upper extremity muscular endurance
Zeitfenster: Before single limb exercise regime and on completion (at 8 weeks)
The Unsupported Upper Limb Exercise test will be used as secondary outcome measure for upper extremtiy muscular endurance
Before single limb exercise regime and on completion (at 8 weeks)
Isokinetic muscular endurance capacity
Zeitfenster: Before single limb exercise regime and on completion (at 8 weeks)
Endurance capacity in both upper and lower extremity will be evaluated with an isokinetic dynamometer
Before single limb exercise regime and on completion (at 8 weeks)
Self-efficacy
Zeitfenster: Before single limb exercise regime and on completion (at 8 weeks)
Self-efficacy will be evaluated with the exercise self-efficacy scale, and the self-efficacy for walking questionnaire
Before single limb exercise regime and on completion (at 8 weeks)
Anxiety and Depression
Zeitfenster: Before single limb exercise regime and on completion (at 8 weeks)
Anxiety and Depression will be evaluated with the hospital anxiety and depression scale (HADs)
Before single limb exercise regime and on completion (at 8 weeks)
Relationship between muscle fatigue and dyspnea in the different exercise tests
Zeitfenster: Before single limb exercise regime and on completion (at 8 weeks)
Muscle fatigue and dyspnea will be measured using the BORG CR10 scale during all exercise tests before the start of the study and on completion 8 weeks later. The relationship between ratings of muscle fatigue between tests, dyspnea between tests and the relationship between muscle fatigue rating and dyspnea rating between exercise tests will be investigated.
Before single limb exercise regime and on completion (at 8 weeks)
Develop a strategy to optimize resistance for each involved movement within an exercise regimen
Zeitfenster: Before single limb exercise regime and on completion (at 8 weeks)
The exercises used within the intervention group is performed with elastic resistance. How much the elastic band is stretched for the different exercises is determined by a literature search investigation the strenght relationship between the muscles/movements used in the study. During the study each participant in the intervention group will rate muscle fatigue and dyspnea after each exercise during alla exercise sessions. These rating will be used to develop a strategy to optimize resistance for each involved movement within an exercise regimen
Before single limb exercise regime and on completion (at 8 weeks)
Develop a strategy to minimize attempts needed to determine a multiple repetition resistance using elastic bands
Zeitfenster: Before single limb exercise regime and on completion (at 8 weeks)
55% of the isokinetic peak value obtained during baseline tests will be used to anticipate the 25RM load when using elastic resistance in an attempt to minimize the attempts needed to achieve 25RM.
Before single limb exercise regime and on completion (at 8 weeks)
Determine if this exercise regimen is feasible and safe in stage II-IV COPD patients
Zeitfenster: Before single limb exercise regime and on completion (at 8 weeks)
Feasibility will be evaluated through number of participants attendance, adherence and number of participants developing any side effects or injuries during each training session. In addition, compliance to the different parts of the exercise regimen will be evaluated with a standardized questionnaire by both study participants and physiotherapists leading interventions.
Before single limb exercise regime and on completion (at 8 weeks)
Identify if there are any sex related differences in exercise training effects
Zeitfenster: Before single limb exercise regime and on completion (at 8 weeks)
Statistical analyzes will be used to identify if there are any sex related differences in exercise training effects between male and female patients with COPD
Before single limb exercise regime and on completion (at 8 weeks)
Quality-of-life
Zeitfenster: Before single limb exercise regime and on completion (at 8 weeks)
The clinical COPD questionnaire (CCQ) and the SF-36 scale will be used as secondary outcome measures for Quality-of-life
Before single limb exercise regime and on completion (at 8 weeks)
Exercise capacity
Zeitfenster: Before single limb exercise regime and on completion (at 8 weeks)
A constant work rate test investigating the effects on endurance time, ventilatory response, perceived dyspnea and leg fatigue during submaximal cycle test.
Before single limb exercise regime and on completion (at 8 weeks)

Mitarbeiter und Ermittler

Hier finden Sie Personen und Organisationen, die an dieser Studie beteiligt sind.

Ermittler

  • Hauptermittler: Karin Wadell, Ph.D, Umeå University
  • Studienstuhl: Andre Nyberg, Msc, Umeå University
  • Studienstuhl: Britta Lindström, Ph.D, Umeå University

Publikationen und hilfreiche Links

Die Bereitstellung dieser Publikationen erfolgt freiwillig durch die für die Eingabe von Informationen über die Studie verantwortliche Person. Diese können sich auf alles beziehen, was mit dem Studium zu tun hat.

Studienaufzeichnungsdaten

Diese Daten verfolgen den Fortschritt der Übermittlung von Studienaufzeichnungen und zusammenfassenden Ergebnissen an ClinicalTrials.gov. Studienaufzeichnungen und gemeldete Ergebnisse werden von der National Library of Medicine (NLM) überprüft, um sicherzustellen, dass sie bestimmten Qualitätskontrollstandards entsprechen, bevor sie auf der öffentlichen Website veröffentlicht werden.

Haupttermine studieren

Studienbeginn

1. Mai 2011

Primärer Abschluss (Tatsächlich)

1. Mai 2012

Studienabschluss (Tatsächlich)

1. Juni 2012

Studienanmeldedaten

Zuerst eingereicht

11. Mai 2011

Zuerst eingereicht, das die QC-Kriterien erfüllt hat

13. Mai 2011

Zuerst gepostet (Schätzen)

16. Mai 2011

Studienaufzeichnungsaktualisierungen

Letztes Update gepostet (Schätzen)

21. Juni 2012

Letztes eingereichtes Update, das die QC-Kriterien erfüllt

19. Juni 2012

Zuletzt verifiziert

1. Juni 2012

Mehr Informationen

Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .

Klinische Studien zur Control group

3
Abonnieren